A detailed history of Missouri Trust & Investment CO transactions in Novartis Ag stock. As of the latest transaction made, Missouri Trust & Investment CO holds 578 shares of NVS stock, worth $63,903. This represents 0.02% of its overall portfolio holdings.

Number of Shares
578
Previous 728 20.6%
Holding current value
$63,903
Previous $70,000 12.86%
% of portfolio
0.02%
Previous 0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$92.57 - $107.37 $13,885 - $16,105
-150 Reduced 20.6%
578 $61,000
Q4 2023

Feb 08, 2024

BUY
$92.27 - $101.54 $22,513 - $24,775
244 Added 50.41%
728 $73,000
Q4 2022

Feb 10, 2023

SELL
$75.55 - $92.52 $13,221 - $16,191
-175 Reduced 26.56%
484 $44,000
Q4 2021

Feb 02, 2022

BUY
$79.7 - $88.13 $52,522 - $58,077
659 New
659 $58,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $238B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Missouri Trust & Investment CO Portfolio

Follow Missouri Trust & Investment CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Missouri Trust & Investment CO, based on Form 13F filings with the SEC.

News

Stay updated on Missouri Trust & Investment CO with notifications on news.